Recent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparum
about
Immune mechanisms in malaria: new insights in vaccine developmentHaem-activated promiscuous targeting of artemisinin in Plasmodium falciparumIdentification of Biochemically Distinct Properties of the Small Ubiquitin-related Modifier (SUMO) Conjugation Pathway in Plasmodium falciparumTransmission-blocking strategies: the roadmap from laboratory bench to the communityMolecular evidence of increased resistance to anti-folate drugs in Plasmodium falciparum in North-East India: a signal for potential failure of artemisinin plus sulphadoxine-pyrimethamine combination therapyBiochemical and Structural Characterization of Selective Allosteric Inhibitors of the Plasmodium falciparum Drug Target, Prolyl-tRNA-synthetaseHit-to-lead development of the chamigrane endoperoxide merulin A for the treatment of African sleeping sicknessMitotic evolution of Plasmodium falciparum shows a stable core genome but recombination in antigen familiesA new in vivo screening paradigm to accelerate antimalarial drug discoveryRapid response to selection, competitive release and increased transmission potential of artesunate-selected Plasmodium chabaudi malaria parasitesDiscovery of Antimalarial Azetidine-2-carbonitriles That Inhibit P. falciparum Dihydroorotate DehydrogenaseStructural modification of pantothenamides counteracts degradation by pantetheinase and improves antiplasmodial activityUse of malaria RDTs in various health contexts across sub-Saharan Africa: a systematic review.Simulated impact of RTS,S/AS01 vaccination programs in the context of changing malaria transmissionEx vivo activity of endoperoxide antimalarials, including artemisone and arterolane, against multidrug-resistant Plasmodium falciparum isolates from Cambodia.Altered temporal response of malaria parasites determines differential sensitivity to artemisininEmerging artemisinin resistance in the border areas of Thailand.Diversity-oriented synthesis-facilitated medicinal chemistry: toward the development of novel antimalarial agentsWhole-cell in vitro screening for gametocytocidal compounds.Mutations in Plasmodium falciparum K13 propeller gene from Bangladesh (2009-2013).Pantothenamides are potent, on-target inhibitors of Plasmodium falciparum growth when serum pantetheinase is inactivatedIn silico screening for Plasmodium falciparum enoyl-ACP reductase inhibitorsAnopheles gambiae salivary protein expression modulated by wild Plasmodium falciparum infection: highlighting of new antigenic peptides as candidates of An. gambiae bites.Modeling malaria infection and immunity against variant surface antigens in Príncipe Island, West Africa.In vivo monitoring of dihydroartemisinin-piperaquine sensitivity in Plasmodium falciparum along the China-Myanmar border of Yunnan Province, China from 2007 to 2013Small molecule targeting malaria merozoite surface protein-1 (MSP-1) prevents host invasion of divergent plasmodial species.Development and assessment of plant-based synthetic odor baits for surveillance and control of malaria vectors.Utilizing diversity-oriented synthesis in antimicrobial drug discovery.Development of a genetic tool for functional screening of anti-malarial bioactive extracts in metagenomic librariesIn vitro and in vivo activity of solithromycin (CEM-101) against Plasmodium speciesDesign, structure prediction and molecular dynamics simulation of a fusion construct containing malaria pre-erythrocytic vaccine candidate, PfCelTOS, and human interleukin 2 as adjuvant.Selection of mosquito life-histories: a hidden weapon against malaria?Plasmodium subtilisin-like protease 1 (SUB1): insights into the active-site structure, specificity and function of a pan-malaria drug target.Assessment of Anopheles salivary antigens as individual exposure biomarkers to species-specific malaria vector bitesDiscovery-2: an interactive resource for the rational selection and comparison of putative drug target proteins in malaria.Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies.Challenges in diagnosing paediatric malaria in Dar es Salaam, Tanzania.Direct comparison of the histidine-rich protein-2 enzyme-linked immunosorbent assay (HRP-2 ELISA) and malaria SYBR green I fluorescence (MSF) drug sensitivity tests in Plasmodium falciparum reference clones and fresh ex vivo field isolates from CambTorins are potent antimalarials that block replenishment of Plasmodium liver stage parasitophorous vacuole membrane proteins.A clinical and molecular study of artesunate + sulphadoxine-pyrimethamine in three districts of central and eastern India
P2860
Q21032484-E09B2420-6344-4C9C-BB73-A9B17E26ED60Q22061870-46275055-C11E-4950-9DCB-2821F6427C21Q27679557-0A4CC029-801A-47DE-AF4A-7A706C725903Q28078982-60DCFAF1-812A-448F-B706-2328E550624CQ28125911-D4064385-2C66-49AE-A9CB-58353BB0EB50Q28468285-470A01F4-3470-4902-BCFA-0BA47A9A311CQ28484074-DB1C3042-330B-48F1-A4BA-D2CD218CC2DCQ28486079-1BF7A8F6-15F7-4540-83CB-A007003B439FQ28534314-993AE3BA-9482-4A45-AD69-74032800D6DDQ28538245-F4FB48A0-4AD6-4DB0-88AC-2ED87C2C0801Q30041606-B01461CD-B716-48C1-B6C3-21AD074AE651Q33636093-EC2665A3-5B68-4042-8F5D-6436194AA8A6Q33706776-81A189EE-4DE2-4377-8A83-65B76AB15AACQ34193236-CB811E35-53B0-41C1-BDCD-935FC61A6289Q34298916-07FFE6A2-004B-4B0A-810D-84901DB639C0Q34329125-5F8EDE53-8E48-41FD-8BCE-228EEE0F26E6Q34343530-5C00B371-B193-4FC3-941F-93664F37EEE8Q34394236-6C698977-13D3-4EBE-B173-80F3973E570AQ34509609-FD57674E-812B-455B-9B08-8FC3CFE831FBQ34558564-9A756A1D-FBBC-4386-AFA1-7B153F04B375Q34584014-693F81E2-06D3-4749-B6A0-E24B91357349Q34785012-7DC1F64E-815B-48D9-8AB0-4B55D1E3EF57Q34875709-A4E5A4C3-4E3D-476F-BF45-D05DA67E0C3BQ35092698-8DDEF5D4-B743-4176-8ABD-2C79EA1C5C2EQ35099599-0BCE64E8-744B-4651-8C0D-0173A619F170Q35102544-4D16296B-E9ED-4757-8ABF-ACB766C82A92Q35108165-B35EE0F4-D79C-4904-BF81-113D971C4E2EQ35510383-E5211382-7BB1-440D-9005-4C13E1A22178Q35651804-0B62B8D0-46A8-41CB-B342-5469B85FCA2CQ35689416-8A1F4EC1-F497-4363-9118-9DBE2C6DFEFEQ35916544-F2110310-9E9C-4064-A7A6-42F1F0AEFE36Q35998512-F6512DF2-B52D-4EB0-84EB-3B132FBAFA98Q36045121-FFA47D66-6253-42D8-8DDF-EF86A817BE5AQ36541673-C33B478D-6675-4491-9930-54D1C00E06F4Q36797403-6BE53018-3F20-40E1-AED7-5D9F5FF4B0C2Q36919648-2603D388-C0D7-4455-9A01-4F26DB1B1E01Q36988178-64BE4181-C671-42D7-8F29-75DB59C6294CQ37028482-88E3E8FE-EDF3-442A-A589-5363C55BAC2EQ37049536-476F5BD3-2CC1-4C86-A219-CB6FA4ED3E3BQ37053376-BD9E19EA-C481-4D53-B6B4-2ECCE084371F
P2860
Recent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparum
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Recent clinical and molecular ...... tance in Plasmodium falciparum
@ast
Recent clinical and molecular ...... tance in Plasmodium falciparum
@en
Recent clinical and molecular ...... tance in Plasmodium falciparum
@en-gb
Recent clinical and molecular ...... tance in Plasmodium falciparum
@nl
type
label
Recent clinical and molecular ...... tance in Plasmodium falciparum
@ast
Recent clinical and molecular ...... tance in Plasmodium falciparum
@en
Recent clinical and molecular ...... tance in Plasmodium falciparum
@en-gb
Recent clinical and molecular ...... tance in Plasmodium falciparum
@nl
prefLabel
Recent clinical and molecular ...... tance in Plasmodium falciparum
@ast
Recent clinical and molecular ...... tance in Plasmodium falciparum
@en
Recent clinical and molecular ...... tance in Plasmodium falciparum
@en-gb
Recent clinical and molecular ...... tance in Plasmodium falciparum
@nl
P2093
P2860
P921
P3181
P1476
Recent clinical and molecular ...... tance in Plasmodium falciparum
@en
P2093
Connor O'Brien
Neha Passi
Philipp P Henrich
P2860
P3181
P356
10.1097/QCO.0B013E32834CD3ED
P407
P577
2011-12-01T00:00:00Z